biote Corp. splits its revenue into 7 lines in its filings. The largest line in fiscal 2025, which ended Dec 31, 2025 was Pellet Procedures Product Revenue at $137.0 million, 71% of the total.
USD in millions. The percent under a figure is the change from the year before.
| Line |
FY 2026
Jun 30, 2026
|
FY 2025
Dec 31, 2025
|
FY 2024
Dec 31, 2024
|
FY 2023
Dec 31, 2023
|
FY 2022
Dec 31, 2022
|
FY 2021
Dec 31, 2021
|
|---|---|---|---|---|---|---|
| Revenue |
184
|
192
|
197
|
185
|
165
|
—
|
| Pellet Procedures Product Revenue |
127
-12.6%
share 69.4%
|
137
-8.8%
share 71.3%
|
150
+6.6%
share 76.2%
|
141
+9.3%
share 76.1%
|
129
share 78.2%
|
—
|
| Dietary Supplements |
45
+12.0%
share 24.7%
|
43
+19.1%
share 22.3%
|
36
-5.4%
share 18.3%
|
38
+17.5%
share 20.5%
|
32
share 19.6%
|
—
|
| Disposable Trocars Product Revenue |
—
|
—
|
4
share 2.2%
|
—
|
2
share 1.0%
|
—
|
| Service Revenue |
—
|
—
|
—
|
3
share 1.5%
|
—
|
—
|
| Other Service Revenue |
—
|
—
|
2
+225.5%
share 1.2%
|
1
share 0.4%
|
—
|
—
|
| Shipping Fees And Other Product Revenue |
2
+4.3%
share 1.1%
|
2
+38.9%
share 1.1%
|
2
+800.0%
share 0.8%
|
0
+142.3%
share 0.1%
|
0
share 0.0%
|
—
|
| Training Service Revenue |
1
-55.9%
share 0.4%
|
1
-26.1%
share 0.6%
|
1
share 0.7%
|
—
|
1
share 0.6%
|
—
|
How these figures are calculated
Annual columns are full-year amounts from the annual report (Form 10-K, 20-F, or 40-F). If a company restates a year, the latest filed number is shown. USD in millions. Each group is a separate split of total revenue, so the groups are not added together. Share of revenue is that line divided by total revenue. The first column adds the latest year-to-date segment amount to the last fiscal year and subtracts the year-ago year-to-date amount. More on our methodology.
Company profile
- Industry
- Medicinal Chemicals & Botanical Products (SIC 2833)
- Listed as
- BTMD (Nasdaq)
- Fiscal year ends
- December 31
- Headquarters
- Irving, TX
- SEC filer status
- Accelerated filer, Smaller reporting company, Emerging growth company
- SEC CIK
- 1819253
- Former names
- Haymaker Acquisition Corp. III (until May 25, 2022)
Other Medicinal Chemicals & Botanical Products companies
- Definium Therapeutics, Inc. DFTX
- Regencell Bioscience Holdings Ltd RGC
- Curaleaf Holdings, Inc. CURLF
- Trulieve Cannabis Corp. TRLV
- Cronos Group Inc. CRON
- TFA Therapeutics, Inc. RAJAF
- Tilray Brands, Inc. TLRY
- SNDL Inc. SNDL
Source: SEC EDGAR filings. This is company-reported data, not investment advice.